Abstract
Amyloid beta (Abeta) is considered to be responsible for the pathogenesis of Alzheimer's disease (AD). Mitochondrial and ER apoptotic pathways are considered to be involved in this process. Galantamine is an acetylcholinesterase (AChE) inhibitor widely used for patients with AD. In this study, we investigated the neuroprotective effects of galantamine on Abeta(25-35)-induced apoptosis in PC12 cells and the underlying mechanisms. Exposure of PC12 cells to 20 microM Abeta(25-35) caused significant cell viability loss and apoptosis, Abeta aggregation, mitochondrial and ER morphological changes, as well as mitochondrial membrane potential dissipation, reactive oxygen species (ROS) production, intracellular calcium elevation, and cytochrome c release from mitochondria. Pretreatment with 10 microM galantamine for 24 h prior to Abeta(25-35) exposure significantly reduced Abeta(25-35)-induced apoptosis not only by preventing Abeta aggregation, mitochondrial and ER morphological changes, mitochondrial membrane potential dissipation, ROS production, intracellular calcium elevation, and cytochrome c release, but also via reversing Bcl-2/Bax ratio and suppressing the activity of GADD153, Grp78/94, caspase-9, caspase-12, and caspase-3. All ...Continue Reading
References
Oct 12, 1990·Science·B A YanknerD A Kirschner
Sep 1, 1989·Journal of Neurochemistry·A Ambrosini, J Meldolesi
Jul 12, 1996·Cell·X LiuX Wang
Aug 1, 1997·Trends in Biochemical Sciences·D W Nicholson, N A Thornberry
Dec 9, 1997·Cell·P LiX Wang
Jan 19, 2000·Nature·T NakagawaJ Yuan
Jul 12, 2001·The Journal of Biological Chemistry·C ZhangS Kitajima
Jun 12, 2002·The Journal of Biological Chemistry·Karie N DahlgrenMary Jo LaDu
Sep 3, 2002·Proceedings of the National Academy of Sciences of the United States of America·Simona CapsoniAntonino Cattaneo
Apr 10, 2003·Free Radical Biology & Medicine·Jung-Hee Jang, Young-Joon Surh
Nov 19, 2003·Biochemistry·Silvia DanteNorbert A Dencher
Dec 5, 2003·Neuropharmacology·Esperanza AriasManuela G López
Jan 10, 2004·Journal of Neurochemistry·Ka-Chun SuenJacques Hugon
Jan 28, 2004·Free Radical Biology & Medicine·Haiyan ZengBaolu Zhao
May 4, 2004·The Journal of Pharmacology and Experimental Therapeutics·Shigeki MoriguchiToshio Narahashi
Jul 13, 2004·Neuroscience Letters·Mónica SobradoAntonio G García
Jan 11, 2005·Brain Research Bulletin·Hugo Geerts
Feb 8, 2005·Brain Research·Hugo GeertsSohel Sachak
Sep 8, 2005·The Journal of Pharmacology and Experimental Therapeutics·Esperanza AriasManuela G López
Jun 15, 2006·Alzheimer Disease and Associated Disorders·Akinori Akaike
Sep 26, 2006·European Journal of Pharmacology·Yuki Takada-TakatoriAkinori Akaike
Jan 2, 2007·Chemico-biological Interactions·Silvia C LenzkenMarco Racchi
Mar 3, 2007·Psychosomatics·Benjamin JohnsonShree Bhalerao
May 29, 2007·The Journal of Pharmacology and Experimental Therapeutics·Silvia LorrioManuela G López
Nov 16, 2007·The European Journal of Neuroscience·Yi YangXiaoxiang Zheng
Jan 15, 2008·Neurotoxicology·Miezan J M EzoulinFrance Massicot
Dec 23, 2008·Life Sciences·Donggeun SulSo-Young Park
Feb 19, 2009·The European Journal of Neuroscience·Joana B MeloPaula Agostinho
Mar 3, 2009·Biological & Pharmaceutical Bulletin·Yuki Takada-TakatoriAkinori Akaike
Mar 3, 2009·Hippocampus·Shigeki MoriguchiKohji Fukunaga
Apr 8, 2009·Current Neurology and Neuroscience Reports·Bingwei Lu
May 27, 2009·Atherosclerosis·Xu KediZheng Xiaoxiang
Aug 4, 2009·Free Radical Biology & Medicine·Yuki NakajimaTetsuya Konishi
Citations
Dec 6, 2012·Archives of Pharmacal Research·Bo Ra AhnJae Sue Choi
Mar 29, 2013·International Journal of Pharmaceutics·Maluta S MufamadiViness Pillay
Aug 1, 2012·PloS One·Ehsan KachooeiNader Sheibani
Jun 7, 2011·Drugs & Aging·Melanie-Jayne R Howes, Elaine Perry
Dec 25, 2012·International Journal of Molecular Sciences·Bidur BhandaryHan-Jung Chae
Nov 15, 2013·Biological & Pharmaceutical Bulletin·Shuwei MaXiantao Zhang
Jun 3, 2014·Biological & Pharmaceutical Bulletin·Sunyoung KimJungsook Cho
Jun 17, 2014·Neurochemistry International·Huimin YuZhicheng Liu
Oct 23, 2013·African Journal of Traditional, Complementary, and Alternative Medicines : AJTCAM·Emanuel A AdewusiVanessa Steenkamp
Feb 20, 2013·Neurochemical Research·Song-Zhi KongZi-Ren Su
May 9, 2015·Molecular Medicine Reports·Ji LiLin Zou
Aug 7, 2014·Journal of Biomedical Science·Rita U OstrovskayaSergey B Seredenin
Aug 12, 2015·The Journal of Nutritional Biochemistry·Ruozhi ZhaoGarry X Shen
Oct 14, 2014·Neurological Research·Han-Chang HuangZhao-Feng Jiang
Jul 18, 2015·PloS One·Mansooreh MazaheriNader Sheibani
Jun 9, 2016·Cellular and Molecular Neurobiology·Rong YangHua-Rong Yu
Nov 5, 2016·Neurotoxicology·Willian O CastilloCatarina S Takahashi
Mar 8, 2016·International Journal of Molecular Sciences·Hafiz Maher Ali ZeeshanHan-Jung Chae
Feb 16, 2018·Molecular Nutrition & Food Research·Ke DuMinjie Wei
Sep 6, 2018·International Journal of Molecular Sciences·Julia RelatM Victòria Clos
Feb 9, 2012·Molecular Biology Reports·Huimin DongMingmin Yan
Jul 22, 2017·International Journal of Molecular Medicine·Ahong ChenYu Lin
Nov 7, 2019·Journal of Neurochemistry·Trevor W Stone
Jul 19, 2013·Journal of Neuroscience Research·Xiao-Wen ZhouHuan-Min Luo
Dec 6, 2018·Frontiers in Cellular Neuroscience·Xuyan JinMun-Yong Lee
Jan 8, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Caiyun ZhangXia Li
Feb 28, 2018·Frontiers in Aging Neuroscience·Devesh TewariAtanas G Atanasov
Jul 3, 2020·Neurotoxicity Research·Willian Orlando CastilloSilvana Giuliatti
Jan 6, 2021·Antioxidants·Yeonsoo OhJungsook Cho
Jan 29, 2021·Neuropeptides·Vibhav Varshney, Debapriya Garabadu
May 31, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Barnabas Wilson, Kannoth Mukundan Geetha
Apr 10, 2021·Life Sciences·Mohamed A El-EmamMennatallah A Gowayed
Apr 9, 2021·European Journal of Medicinal Chemistry·Xin JinMing-Yan Liu